Uroplasty, Inc. (UPI) Files Registration for $10M Equity Offering
More News related to UPI
- After-Hours Movers 6/4: UPI, GES, ULTA Higher; CAE, MWE, ALOG, XIDE, BXP Lower
- Uroplasty (UPI) Reports Q4 Loss of $0.11
- Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results
- Uroplasty to Issue Fourth Fiscal Quarter and Full Year Results on June 4, 2009
- Uroplasty (UPI) Reports a Q4 Loss
Uroplasty, Inc. (AMEX: UPI) today announced it has filed a registration statement with the SEC in regards to a proposed public offering of $10 million of its common stock. Craig-Hallum Capital Group and Noble International Investments, Inc will act as underwriters in connection with this proposed public offering.
Uroplasty, Inc. (Uroplasty) is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. Uroplasty’s products treat urinary and fecal incontinence and overactive bladder symptoms. It offers a diverse set of products to address the various preferences of doctors and patients
Related Categories
Equity OfferingsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
